LifeMD (LFMD)
(Delayed Data from NSDQ)
$5.24 USD
+0.04 (0.77%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $5.25 +0.01 (0.19%) 7:54 PM ET
4-Sell of 5 4
C Value A Growth C Momentum A VGM
Balance Sheet
Fiscal Year End for LifeMD, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 33 | 4 | 41 | 9 | 1 |
Receivables | 5 | 3 | 1 | 1 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 3 | 4 | 2 | 1 | 1 |
Other Current Assets | 1 | 1 | 1 | 1 | 1 |
Total Current Assets | 43 | 11 | 45 | 12 | 3 |
Net Property & Equipment | 12 | 9 | 3 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 3 | 4 | 0 | 0 | 1 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 58 | 26 | 50 | 13 | 3 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 3 | 0 | 1 | 1 |
Accounts Payable | 11 | 10 | 21 | 12 | 3 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 14 | 12 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 9 | 6 | 2 | 1 | 0 |
Total Current Liabilities | 35 | 31 | 23 | 13 | 4 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 18 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 1 | 0 | 0 | 1 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 53 | 33 | 24 | 14 | 5 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 5 | 4 | 4 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 1 |
Capital Surplus | 218 | 179 | 165 | 78 | 15 |
Retained Earnings | -214 | -191 | -142 | -80 | -17 |
Other Equity | 2 | 0 | -1 | -2 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 6 | -7 | 26 | -1 | -1 |
Total Liabilities & Shareholder's Equity | 58 | 26 | 50 | 13 | 3 |
Total Common Equity | 6 | -12 | 22 | -4 | -1 |
Shares Outstanding | 37.90 | 31.40 | 30.50 | 23.10 | 10.60 |
Book Value Per Share | 0.15 | -0.38 | 0.71 | -0.19 | -0.11 |
Fiscal Year End for LifeMD, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 36 | 35 | 33 | 15 | 12 |
Receivables | 6 | 5 | 5 | 4 | 4 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 2 | 2 | 3 | 4 | 4 |
Other Current Assets | 2 | 2 | 1 | 1 | 1 |
Total Current Assets | 45 | 44 | 43 | 25 | 20 |
Net Property & Equipment | 14 | 13 | 12 | 12 | 11 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 3 | 3 | 3 | 3 | 4 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 64 | 61 | 58 | 41 | 35 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 1 |
Accounts Payable | 15 | 12 | 11 | 10 | 10 |
Current Portion Long-Term Debt | 6 | 4 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 15 | 15 | 14 | 15 | 15 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 15 | 13 | 9 | 6 | 6 |
Total Current Liabilities | 52 | 45 | 35 | 33 | 32 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 12 | 14 | 18 | 19 | 14 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 66 | 60 | 53 | 52 | 46 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 5 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 225 | 221 | 218 | 197 | 187 |
Retained Earnings | -229 | -222 | -214 | -210 | -203 |
Other Equity | 2 | 2 | 2 | 2 | 1 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | -2 | 1 | 6 | -11 | -10 |
Total Liabilities & Shareholder's Equity | 64 | 61 | 58 | 41 | 35 |
Total Common Equity | -2 | 1 | 6 | -11 | -15 |
Shares Outstanding | 41.70 | 40.80 | 37.90 | 36.00 | 32.40 |
Book Value Per Share | -0.05 | 0.03 | 0.15 | -0.31 | -0.47 |